Jones Financial Companies’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240M Buy
506,040
+345,310
+215% +$187M 0.12% 89
2025
Q4
$93.1M Buy
160,730
+8,095
+5% +$4.58M 0.06% 107
2025
Q3
$71.6M Buy
152,635
+23,609
+18% +$11M 0.05% 120
2025
Q2
$52.6M Buy
129,026
+25,043
+24% +$10.5M 0.04% 139
2025
Q1
$51.9M Buy
103,983
+17,068
+20% +$9.24M 0.05% 107
2024
Q4
$45.2M Buy
86,915
+18,762
+28% +$10.3M 0.04% 94
2024
Q3
$42M Buy
68,153
+15,423
+29% +$9.13M 0.04% 81
2024
Q2
$29.2M Buy
52,730
+16,079
+44% +$9.21M 0.03% 77
2024
Q1
$21.3M Buy
36,651
+2,855
+8% +$1.6M 0.03% 76
2023
Q4
$17.9M Buy
33,796
+847
+3% +$410K 0.03% 74
2023
Q3
$16.7M Sell
32,949
-884
-3% -$471K 0.03% 72
2023
Q2
$17.7M Sell
33,833
-449
-1% -$242K 0.03% 71
2023
Q1
$19.8M Sell
34,282
-594
-2% -$335K 0.03% 65
2022
Q4
$19.2M Buy
34,876
+155
+0.4% +$82.1K 0.03% 67
2022
Q3
$17.6M Sell
34,721
-153
-0.4% -$85.6K 0.03% 59
2022
Q2
$18.9M Sell
34,874
-1,314
-4% -$723K 0.03% 59
2022
Q1
$21.4M Sell
36,188
-695
-2% -$399K 0.03% 62
2021
Q4
$24.6M Sell
36,883
-1,164
-3% -$727K 0.03% 60
2021
Q3
$21.7M Sell
38,047
-1,408
-4% -$773K 0.03% 59
2021
Q2
$19.9M Sell
39,455
-421
-1% -$199K 0.03% 65
2021
Q1
$18.2M Buy
39,876
+715
+2% +$341K 0.03% 67
2020
Q4
$18.2M Buy
39,161
+462
+1% +$217K 0.03% 64
2020
Q3
$17.1M Sell
38,699
-1,998
-5% -$825K 0.04% 62
2020
Q2
$14.7M Sell
40,697
-2,325
-5% -$779K 0.03% 63
2020
Q1
$12.2M Sell
43,022
-743
-2% -$234K 0.03% 67
2019
Q4
$14.2M Sell
43,765
-1,206
-3% -$366K 0.03% 65
2019
Q3
$13.1M Sell
44,971
-435
-1% -$125K 0.03% 66
2019
Q2
$13.3M Sell
45,406
-191
-0.4% -$52.6K 0.03% 68
2019
Q1
$12.5M Sell
45,597
-1,302
-3% -$324K 0.03% 66
2018
Q4
$10.5M Sell
46,899
-1,353
-3% -$317K 0.03% 66
2018
Q3
$11.8M Sell
48,252
-543
-1% -$125K 0.03% 68
2018
Q2
$10.1M Sell
48,795
-239
-0.5% -$50.7K 0.02% 70
2018
Q1
$10.1M Sell
49,034
-1,502
-3% -$315K 0.02% 64
2017
Q4
$9.6M Sell
50,536
-2,194
-4% -$420K 0.02% 70
2017
Q3
$9.98M Sell
52,730
-2,141
-4% -$388K 0.03% 65
2017
Q2
$9.57M Sell
54,871
-471
-0.9% -$79.1K 0.03% 67
2017
Q1
$8.5M Buy
55,342
+149
+0.3% +$22.8K 0.03% 69
2016
Q4
$7.79M Buy
55,193
+1,233
+2% +$182K 0.03% 69
2016
Q3
$8.58M Sell
53,960
-3,728
-6% -$574K 0.03% 63
2016
Q2
$8.52M Sell
57,688
-2,061
-3% -$304K 0.04% 60
2016
Q1
$8.46M Buy
59,749
+1,021
+2% +$137K 0.05% 56
2015
Q4
$8.33M Sell
58,728
-1,039
-2% -$139K 0.05% 55
2015
Q3
$7.31M Buy
59,767
+1,025
+2% +$134K 0.05% 59
2015
Q2
$7.62M Sell
58,742
-167
-0.3% -$21.8K 0.05% 59
2015
Q1
$7.91M Buy
58,909
+1,964
+3% +$253K 0.05% 59
2014
Q4
$7.13M Buy
56,945
+2,693
+5% +$327K 0.05% 61
2014
Q3
$6.6M Buy
54,252
+1,943
+4% +$236K 0.05% 60
2014
Q2
$6.17M Buy
52,309
+1,328
+3% +$156K 0.05% 63
2014
Q1
$6.13M Sell
50,981
-5,273
-9% -$627K 0.05% 61
2013
Q4
$6.26M Sell
56,254
-1,922
-3% -$191K 0.06% 57
2013
Q3
$5.36M Buy
58,176
+4,028
+7% +$364K 0.05% 60
2013
Q2
$4.58M Buy
+54,148
New +$4.51M 0.05% 63

Other funds holding TMO

Jones Financial Companies's TMO Position: Q1 2026 in Review

Jones Financial Companies increased its Thermo Fisher Scientific (TMO) stake by 215% in Q1 2026, buying an estimated $187M and bringing the position to 506,040 shares worth $240M. The position accounts for 0.12% of the portfolio, ranked #89.

Jones Financial Companies first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Jones Financial Companies held 506,040 shares of Thermo Fisher Scientific worth $240M as of Q1 2026.
  • Jones Financial Companies bought 345,310 Thermo Fisher Scientific shares in Q1 2026, an estimated $187M.
  • Thermo Fisher Scientific made up 0.12% of Jones Financial Companies's portfolio in Q1 2026, its #89 holding.
  • Jones Financial Companies first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.